Outbreak of hepatitis A virus infection in travellers returning from Egypt
Between 1 November 2012 and 30 April 2013, 15 confirmed cases of hepatitis A virus infections with subgenotype IB and identical RNA sequence, and 89 probable cases, have been reported in 14 EU/EFTA countries. All cases have a travel history to Egypt.
Due to the fact that 15 of these cases, identified in three different countries, have identical sequences, a multistate outbreak has been confirmed with exposure occurring in Egypt. The descriptive epidemiology points to a possible persistent common source of infection contaminated with viruses sharing an identical sequence.Preliminary epidemiological investigations in affected countries do not definitively point to any particular source of infection. RNA sequencing of probable cases and interviews of probable and confirmed cases should enable the development of a more conclusive hypothesis on the source of infection.
Threat Assessment Brief: Implications of the further emergence and spread of the SARS CoV 2 B.1.1.529 variant of concern (Omicron) for the EU/EEA first update
2 Dec 2021 - The number of countries reporting SARS-CoV-2 Omicron variant of concern (VOC) cases continues to increase globally, with a total of 352 confirmed cases reported by 27 countries as of 16.00 on 1 December 2021, including 70 confirmed cases reported by 13 European Union and European Economic Area (EU/EEA) countries.
Threat Assessment Brief: Implications of the emergence and spread of the SARS-CoV-2 B.1.1. 529 variant of concern (Omicron) for the EU/EEA
26 Nov 2021 - A SARS-CoV-2 variant belonging to Pango lineage B.1.1.529, with a high number of S-gene mutations compared to the original virus was detected at the beginning of November 2021. On 26 November 2021 the variant was designated a variant of concern (VOC) and assigned the label Omicron by the World Health Organization (WHO).
Assessment of the current SARS-CoV-2 epidemiological situation in the EU/EEA, projections for the end-of-year festive season and strategies for response, 17th update
24 Nov 2021 - This Rapid Risk Assessment assesses the risk posed by the circulation of the Delta variant of SARS-CoV-2 between 1 December 2021 to 31 January 2022, based on modelling scenarios and projected levels of vaccination coverage.